PARIS, Jan 4 (Reuters) - Shares in biotech company Valneva
were suspended briefly on the Paris stock market on
Tuesday after dropping sharply.
Valneva's share price has fluctuated in the past few weeks
on news about the company's COVID-19 vaccine candidate. It is
awaiting regulatory approval of the shot in the European Union
and Britain.
Valneva shares recorded a drop of 23% on Tuesday afternoon
before trading was suspended. Trading resumed later and by 1620
GMT the stock was down 23.4%.
At their lowest point on Tuesday, Valneva shares were
trading at 17.17 euros ($19.38), the lowest since October last
year.
It was not immediately clear what caused the stock to fall
on Tuesday. Shares in COVID-19 vaccine makers Moderna,
Pfizer and GlaxoSmithKline also fell on Tuesday,
but those drops were in low single figures.
($1 = 0.8857 euros)
(Reporting by Tassilo Hummel and Clement Martinot
Writing by Christian Lowe
Editing by David Goodman
)